Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent Strokes

CONCLUSIONS: Apixaban is generally safe for patients with ischemic stroke. Increased primary outcomes in stroke patients may in part be attributed to the presence of cerebral atherosclerotic lesions, suggesting that further studies are needed to establish therapeutic strategies in this population.PMID:35135065 | DOI:10.5853/jos.2021.02355

Source: Atherosclerosis - February 8, 2022 Category: Cardiology Authors: Jong S Kim Jaseong Koo Dong-Ick Shin Byung-Su Kim Jei Kim Eung-Gyu Kim Keun-Sik Hong Hyeju Yi Source Type: research